A pan-cancer lncRNA analysis has shown that NEAT1 is overexpressed in tumor tissues, including bladder urothelial carcinoma, cervical squamous cell carcinoma, cholangiocarcinoma, colon carcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, kidney clear cell carcinoma, hepatocellular carcinoma, pancreatic cancer, prostate cancer, gastric cancer, and thyroid cancer32. Here, NEAT1 is linked to cholangiocarcinoma.